In memoriam: Ulrich auf dem Keller
Ulrich auf dem Keller, a leader in wound healing research and mass spectrometry-based proteomics technology, died September 1, 2023 at the age of 49.

Born on April 5, 1974 and raised in Mu虉lheim an der Ruhr, Germany, auf dem Keller received his undergraduate diploma in biochemistry in 2000. He then joined ETH, Zurich in the biology department under the mentorship of Pfizer Academic Award winner where he identified Nrf2 as a key player in the cellular stress response and studied Nrf-mediated gene expression in keratinocytes in the prevention of skin tumors. He obtained his Ph.D. in 2005.
auf dem Keller moved to the Centre for Blood Research, Vancouver, Canada, in 2006 to join where he quantified changes in the proteome and analyzed the nature of protein amino termini analysis (N-terminome) using iTRAQ-TAILS technology and showed that loss of a single protease could perturb the proteolytic signaling network and enhance inflammation.
In 2009, auf dem Keller started an independent lab in ETH, Zurich as a senior scientist and group leader. He exploited the capability of iTRAQ-TAILS to exploring the substrate degradome of matrix metalloproteinase and translated his research to address complex proteolytic activities in healing impairments. In 2017, he moved to the section of protein science and biotherapeutics at Technical University of Denmark Bioengineering in Lyngby as a professor. He continued there until his death, exploring the quantitative proteomics approach in complex biological matrices.
auf dem Keller had more than 150 publications with 6,587 citations to date. He received a Herbert Tabor Young Investigator Award in 2011 from the 精品国产一区二区桃色 for his studies of proteolytic events in the skin.
Colleagues remember auf dem Keller as . He was instrumental in the overall growth of his department and his students. He spoke Latin and ancient Greek, had an interest in classical music and was an outstanding viola player.
He is survived by his wife and two children.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.